top of page

ViiV 2DR


Patients living with HIV are treated with many drug regimens. It's common for HCPs to prescribe 3-drug (3DR) regimens. This is common place in the HIV category. These 3DR regimens helped but the cumulative side effects can cause more harm for patients. ViiV set out to change that with their portfolio of products. They were determined to make HIV a smaller part of patient's lives. Research showed HCP's felt that 2DRs didn't work as well as 3DRs. With that, we identified that the attributes of 2DR are the very things that made HCPs uneasy. Fewer drugs, Less ARV exposure and a new era in treatment. This idea faced the facts head on and helped HCPs understand why its important to evolve their prescribing habits. 

bottom of page